- Home
- REPL vs MRNO Comparison
REPL vs MRNO Comparison
Compare REPL & MRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- MRNO
- Stock Information
- Founded
- REPL 2015
- MRNO 2021
- Country
- REPL United States
- MRNO United Kingdom
- Employees
- REPL N/A
- MRNO N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- MRNO
- Sector
- REPL Health Care
- MRNO
- Exchange
- REPL Nasdaq
- MRNO NYSE
- Market Cap
- REPL 757.8M
- MRNO 739.2M
- IPO Year
- REPL 2018
- MRNO N/A
- Fundamental
- Price
- REPL $9.35
- MRNO $9.90
- Analyst Decision
- REPL Strong Buy
- MRNO
- Analyst Count
- REPL 7
- MRNO 0
- Target Price
- REPL $20.83
- MRNO N/A
- AVG Volume (30 Days)
- REPL 1.1M
- MRNO 12.9K
- Earning Date
- REPL 08-07-2025
- MRNO 08-25-2025
- Dividend Yield
- REPL N/A
- MRNO N/A
- EPS Growth
- REPL N/A
- MRNO N/A
- EPS
- REPL N/A
- MRNO N/A
- Revenue
- REPL N/A
- MRNO $35,030,945.00
- Revenue This Year
- REPL N/A
- MRNO N/A
- Revenue Next Year
- REPL N/A
- MRNO N/A
- P/E Ratio
- REPL N/A
- MRNO N/A
- Revenue Growth
- REPL N/A
- MRNO 154.65
- 52 Week Low
- REPL $6.44
- MRNO $5.70
- 52 Week High
- REPL $17.00
- MRNO $13.25
- Technical
- Relative Strength Index (RSI)
- REPL 49.55
- MRNO 48.24
- Support Level
- REPL $8.92
- MRNO $8.53
- Resistance Level
- REPL $9.93
- MRNO $11.23
- Average True Range (ATR)
- REPL 0.52
- MRNO 0.86
- MACD
- REPL -0.08
- MRNO 0.01
- Stochastic Oscillator
- REPL 22.40
- MRNO 46.48
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About MRNO MURANO GLOBAL INVESTMENTS LIMITED
Murano Global Investments PLC is a real estate company that owns, develops, and invests in hotel, resort, and commercial properties throughout Mexico. Its portfolio includes the Andaz and Mondrian Hotels in Mexico City and Vivid Hotel Grand Island. The revenues are derived from the products and services provided to customers such as Room rentals, Food and beverage, Private events, Spa services, and Other services.